Zelis, a healthcare technology company, launched a new AI solution last week that seeks to help payers manage issues with the Independent Dispute Resolution process of the No Surprises Act. …
Health
-
-
For decades, cameras in hospital corridors were a valuable tool for capturing forensic evidence, though they were not yet the proactive security asset we see today. That model is changing …
-
Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive. Health tech companies made several …
-
This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended to be comprehensive. If you have news about an executive …
-
Ipsen has become an active dealmaker as it pursues growth in oncology, and its latest move is the $450 million acquisition of Kartos Therapeutics, a clinical-stage biotech whose lead program …
-
On July 1, a change in federal student lending redraws the map of who gets to finance graduate education on favorable terms. It is already being debated in Congress, in …
-
Health
Healthcare’s Most Avoided Question: “How Much Exactly Do You Need, and What Will America Get in Return?”
American healthcare spending has surpassed $5 trillion annually and continues to rise faster than inflation and wages: hospitals warn of financial distress, primary care says it is underfunded, rural hospitals …
-
The flux around CMS Star Ratings continues. Lawsuits from health insurers over Medicare Advantage Star Ratings have increased in recent years, though with varying results. Some plans like SCAN and …
-
A Viridian Therapeutics drug for thyroid eye disease now has FDA approval, making it just the second therapy for this inflammatory disorder and one offering key competitive advantages over the …
-
Health
A Bridge to Nowhere? Medicare’s GLP-1 Coverage Expansion Requires A More Holistic Approach To Weight Management
Medicare is about to launch an experiment of historic scale. Beginning in July, seniors with a diagnosis of obesity will be able to access GLP-1 medications with a $50 co-pay …